ACTINIUM PHARMACEUTICALS, INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of $608.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-29.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2024-03-29
- ACTINIUM PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2023 was $608.00K, a 34.90% decline from fiscal 2022.
- ACTINIUM PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2022 was $934.00K.
- ACTINIUM PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2017 was -$120.87K.
- ACTINIUM PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2016 was -$956.84K.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month as first filed |
|---|---|---|
| 2023-12-31 | $608.00K 10-K · filed 2024-03-29 | |
| 2022-12-31 | $934.00K 10-K · filed 2024-03-29 | |
| 2017-12-31 | -$120.87K 10-K · filed 2019-03-15 | |
| 2016-12-31 | -$956.84K 10-K · filed 2019-03-15 | -$860.46K 10-K · filed 2017-03-16 |
| 2015-12-31 | -$1.30M 10-K · filed 2016-03-11 | |
| 2014-12-31 | $750.07K 10-K · filed 2016-03-11 | |
| 2013-12-31 | $1.42M 10-K · filed 2016-03-11 | $2.08M 10-K · filed 2014-02-28 |
| 2012-12-31 | $1.97M 10-K · filed 2014-02-28 | $1.50M 10-K · filed 2013-03-29 |
| 2011-12-31 | $373.65K 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |